While our in vitro results strongly implicate PAD2 in the profibrotic processes of RA-ILD fibroblasts, future studies will require utilizing PAD2-selective inhibitors or PAD2-deficient mice in our CAIA + bleomycin lung injury RA-ILD model. Here, PADI2 is linked to interstitial lung disease.